Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-03-14

Clinical Trial Update: Effectiveness of ACS in Extreme Preemies [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating antenatal corticosteroids for extreme preemies has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antenatal corticosteroids (betamethasone; dexamethasone)

Snippet

Sponsor: Pediatrix | Conditions: Preterm Labor, Premature Birth | Phase 3 | Status: WITHDRAWN